|
2026-05-21 |
2026-05-20 |
B
Purchase
|
Non-Executive Director
|
79,994
-49.7%
401.38
US$336,008
|
79,994
-49.7%
|
401.38
|
US$336,008
|
|
|
2026-05-21 |
2026-05-20 |
B
Purchase
|
Non-Executive Director
|
78,167
-2.8%
187.20
US$1,227,691
|
78,167
-2.8%
|
187.20
|
US$1,227,691
|
|
|
2026-05-21 |
2026-05-20 |
B
Purchase
|
Non-Executive Director
|
35,802
-2.6%
186.05
US$354,762
|
35,802
-2.6%
|
186.05
|
US$354,762
|
|
|
2026-05-21 |
2026-05-19 |
B
Purchase
|
Non-Executive Director
|
2,200
+23.3%
56.95
US$125,279
|
2,200
+23.3%
|
56.95
|
US$125,279
|
|
|
2026-02-03 |
2026-02-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
159,701
-10.2%
93.49
US$14,930,526
|
159,701
-10.2%
|
93.49
|
US$14,930,526
|
|
|
2026-02-03 |
2026-02-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
1,200
-0.1%
94.06
US$112,868
|
1,200
-0.1%
|
94.06
|
US$112,868
|
|
|
2026-02-03 |
2026-02-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
159,701
-10.2%
93.49
US$14,930,526
|
159,701
-10.2%
|
93.49
|
US$14,930,526
|
|
|
2026-02-03 |
2026-02-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
1,200
-0.1%
94.06
US$112,868
|
1,200
-0.1%
|
94.06
|
US$112,868
|
|
|
2026-02-02 |
2026-02-02 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
160,901
93.49
US$15,043,390
|
160,901
|
93.49
|
US$15,043,390
|
|
|
2025-12-02 |
2025-12-01 |
PlS
Planned sale
|
EVP& Grp Pres, MedSurg & APAC
Officer
|
17,313
-42.3%
101.55
US$1,758,189
|
17,313
-42.3%
|
101.55
|
US$1,758,189
|
|
|
2025-12-01 |
2025-12-01 |
PrS
Proposed sale
|
Officer
Officer
|
17,313
101.55
US$1,758,188
|
17,313
|
101.55
|
US$1,758,188
|
|
|
2025-11-06 |
2025-11-06 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
2,901
97.96
US$284,171
|
2,901
|
97.96
|
US$284,171
|
|
|
2025-11-06 |
2025-11-06 |
PlS
Planned sale
|
Non-Executive Director
|
12,891
-34.8%
98.28
US$1,266,978
|
12,891
-34.8%
|
98.28
|
US$1,266,978
|
|
|
2025-11-04 |
2025-11-03 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
29,472
-14.2%
99.14
US$2,921,895
|
29,472
-14.2%
|
99.14
|
US$2,921,895
|
|
|
2025-11-04 |
2025-11-03 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
16,928
-7.5%
99.76
US$1,688,749
|
16,928
-7.5%
|
99.76
|
US$1,688,749
|
|
|
2025-11-04 |
2025-11-03 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
3,600
-1.6%
100.75
US$362,693
|
3,600
-1.6%
|
100.75
|
US$362,693
|
|
|
2025-11-03 |
2025-11-03 |
PrS
Proposed sale
|
Officer
Officer
|
50,000
99.47
US$4,973,335
|
50,000
|
99.47
|
US$4,973,335
|
|
|
2025-10-28 |
2025-10-28 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
2,901
102.24
US$296,592
|
2,901
|
102.24
|
US$296,592
|
|
|
2025-10-28 |
2025-10-28 |
PlS
Planned sale
|
Non-Executive Director
|
2,901
-10.7%
102.24
US$296,599
|
2,901
-10.7%
|
102.24
|
US$296,599
|
|
|
2025-10-28 |
2025-10-27 |
PlS
Planned sale
|
Non-Executive Director
|
9,990
-27.0%
101.13
US$1,010,301
|
9,990
-27.0%
|
101.13
|
US$1,010,301
|
|
|
2025-10-27 |
2025-10-27 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
9,990
100.91
US$1,008,081
|
9,990
|
100.91
|
US$1,008,081
|
|
|
2025-10-01 |
2025-10-01 |
PrS
Proposed sale
|
Officer
Officer
|
50,000
98.47
US$4,923,325
|
50,000
|
98.47
|
US$4,923,325
|
|
|
2025-10-01 |
2025-10-01 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
41,755
-19.0%
98.38
US$4,107,844
|
41,755
-19.0%
|
98.38
|
US$4,107,844
|
|
|
2025-10-01 |
2025-10-01 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
8,245
-3.6%
98.91
US$815,482
|
8,245
-3.6%
|
98.91
|
US$815,482
|
|
|
2025-09-03 |
2025-09-02 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
28,170
-13.6%
105.85
US$2,981,755
|
28,170
-13.6%
|
105.85
|
US$2,981,755
|
|
|
2025-09-03 |
2025-09-02 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
21,830
-9.6%
104.89
US$2,289,661
|
21,830
-9.6%
|
104.89
|
US$2,289,661
|
|
|
2025-09-02 |
2025-09-02 |
PrS
Proposed sale
|
Officer
Officer
|
50,000
105.43
US$5,271,415
|
50,000
|
105.43
|
US$5,271,415
|
|
|
2025-08-04 |
2025-08-01 |
PlS
Planned sale
|
EVP& Grp Pres, MedSurg & APAC
Officer
|
17,313
-42.3%
104.63
US$1,811,520
|
17,313
-42.3%
|
104.63
|
US$1,811,520
|
|
|
2025-08-04 |
2025-08-01 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
50,000
-21.9%
104.63
US$5,231,670
|
50,000
-21.9%
|
104.63
|
US$5,231,670
|
|
|
2025-08-01 |
2025-08-01 |
PrS
Proposed sale
|
Officer
Officer
|
17,313
104.63
US$1,811,519
|
17,313
|
104.63
|
US$1,811,519
|
|
|
2025-08-01 |
2025-08-01 |
PrS
Proposed sale
|
Officer
Officer
|
50,000
104.63
US$5,231,665
|
50,000
|
104.63
|
US$5,231,665
|
|
|
2025-07-30 |
2025-07-29 |
S
Sale
|
Non-Executive Director
|
2,901
-58.2%
106.99
US$310,378
|
2,901
-58.2%
|
106.99
|
US$310,378
|
|
|
2025-07-29 |
2025-07-29 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
2,901
106.99
US$310,378
|
2,901
|
106.99
|
US$310,378
|
|
|
2025-07-28 |
2025-07-25 |
S
Sale
|
Non-Executive Director
|
4,000
-17.8%
106.03
US$424,120
|
4,000
-17.8%
|
106.03
|
US$424,120
|
|
|
2025-07-25 |
2025-07-25 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
4,000
107.46
US$429,840
|
4,000
|
107.46
|
US$429,840
|
|
|
2025-07-02 |
2025-07-01 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
50,000
-21.9%
106.97
US$5,348,315
|
50,000
-21.9%
|
106.97
|
US$5,348,315
|
|
|
2025-07-01 |
2025-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
50,000
106.97
US$5,348,310
|
50,000
|
106.97
|
US$5,348,310
|
|
|
2025-06-04 |
2025-06-04 |
PrS
Proposed sale
|
Officer
Officer
|
56,372
102.88
US$5,799,625
|
56,372
|
102.88
|
US$5,799,625
|
|
|
2025-06-04 |
2025-06-04 |
PlS
Planned sale
|
EVP & Group Pres, Cardiology
Officer
|
56,372
-24.0%
102.88
US$5,799,630
|
56,372
-24.0%
|
102.88
|
US$5,799,630
|
|
|
2025-06-03 |
2025-06-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
89,921
-5.7%
103.39
US$9,296,950
|
89,921
-5.7%
|
103.39
|
US$9,296,950
|
|
|
2025-06-03 |
2025-06-02 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
74,522
-4.5%
104.05
US$7,754,186
|
74,522
-4.5%
|
104.05
|
US$7,754,186
|
|
|
2025-06-02 |
2025-06-02 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
164,443
103.69
US$17,051,132
|
164,443
|
103.69
|
US$17,051,132
|
|
|
2025-05-30 |
2025-05-29 |
S
Sale
|
Non-Executive Director
|
4,000
-15.1%
104.59
US$418,368
|
4,000
-15.1%
|
104.59
|
US$418,368
|
|
|
2025-05-29 |
2025-05-29 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
4,000
104.54
US$418,160
|
4,000
|
104.54
|
US$418,160
|
|
|
2025-05-22 |
2025-05-21 |
PlS
Planned sale
|
SVP, GC and Corp. Secretary
Officer
|
4,826
-13.3%
106.42
US$513,583
|
4,826
-13.3%
|
106.42
|
US$513,583
|
|
|
2025-05-21 |
2025-05-21 |
PrS
Proposed sale
|
Officer
Officer
|
4,826
106.42
US$513,583
|
4,826
|
106.42
|
US$513,583
|
|
|
2025-05-06 |
2025-05-05 |
PlS
Planned sale
|
EVP, Global Operations
Officer
|
4,572
-19.6%
104.54
US$477,957
|
4,572
-19.6%
|
104.54
|
US$477,957
|
|
|
2025-05-05 |
2025-05-05 |
PrS
Proposed sale
|
Officer
Officer
|
4,572
104.54
US$477,957
|
4,572
|
104.54
|
US$477,957
|
|
|
2025-05-05 |
2025-05-01 |
PlS
Planned sale
|
EVP& Grp Pres, MedSurg & APAC
Officer
|
17,314
-43.8%
102.06
US$1,766,982
|
17,314
-43.8%
|
102.06
|
US$1,766,982
|
|
|
2025-05-05 |
2025-05-01 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
91,282
-5.6%
102.13
US$9,322,266
|
91,282
-5.6%
|
102.13
|
US$9,322,266
|
|
|
2025-05-05 |
2025-05-01 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
73,161
-4.3%
102.92
US$7,529,708
|
73,161
-4.3%
|
102.92
|
US$7,529,708
|
|
|
2025-05-01 |
2025-05-01 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
164,443
102.48
US$16,851,966
|
164,443
|
102.48
|
US$16,851,966
|
|
|
2025-05-01 |
2025-05-01 |
PrS
Proposed sale
|
Officer
Officer
|
17,314
102.06
US$1,766,981
|
17,314
|
102.06
|
US$1,766,981
|
|
|
2025-04-22 |
2025-04-21 |
PlS
Planned sale
|
SVP, GC and Corp. Secretary
Officer
|
4,826
-11.8%
95.09
US$458,904
|
4,826
-11.8%
|
95.09
|
US$458,904
|
|
|
2025-04-21 |
2025-04-21 |
PrS
Proposed sale
|
Officer
Officer
|
4,826
95.09
US$458,904
|
4,826
|
95.09
|
US$458,904
|
|
|
2025-04-02 |
2025-04-01 |
PlS
Planned sale
|
Chairman, President & CEO
Executive Director
|
164,442
-9.3%
100.01
US$16,445,072
|
164,442
-9.3%
|
100.01
|
US$16,445,072
|
|
|
2025-04-01 |
2025-04-01 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
164,442
100.01
US$16,445,068
|
164,442
|
100.01
|
US$16,445,068
|
|
|
2025-03-24 |
2025-03-21 |
PlS
Planned sale
|
SVP, GC and Corp. Secretary
Officer
|
4,826
-10.5%
100.85
US$486,702
|
4,826
-10.5%
|
100.85
|
US$486,702
|
|
|
2025-03-21 |
2025-03-21 |
PrS
Proposed sale
|
Officer
Officer
|
4,826
100.85
US$486,702
|
4,826
|
100.85
|
US$486,702
|
|
|
2025-03-05 |
2025-03-04 |
PlS
Planned sale
|
SVP, Global Controller and CAO
Officer
|
482
-52.7%
104.63
US$50,432
|
482
-52.7%
|
104.63
|
US$50,432
|
|
|
2025-03-05 |
2025-03-03 |
PlS
Planned sale
|
SVP, Global Controller and CAO
Officer
|
7,149
-88.7%
104.97
US$750,465
|
7,149
-88.7%
|
104.97
|
US$750,465
|
|
|
2025-03-03 |
2025-02-28 |
PlS
Planned sale
|
SVP, Global Controller and CAO
Officer
|
9,887
-85.8%
101.13
US$999,872
|
9,887
-85.8%
|
101.13
|
US$999,872
|
|
|
2025-02-25 |
2025-02-25 |
PrS
Proposed sale
|
Officer
Officer
|
2,688
104.00
US$279,552
|
2,688
|
104.00
|
US$279,552
|
|
|
2025-02-25 |
2025-02-25 |
PlS
Planned sale
|
EVP&Pres, Periph Intervent
Officer
|
2,688
-9.4%
104.00
US$279,552
|
2,688
-9.4%
|
104.00
|
US$279,552
|
|
|
2025-02-25 |
2025-02-24 |
PlS
Planned sale
|
EVP&Pres, Periph Intervent
Officer
|
4,675
-14.1%
104.25
US$487,369
|
4,675
-14.1%
|
104.25
|
US$487,369
|
|
|
2025-02-24 |
2025-02-24 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
13,586
104.23
US$1,416,088
|
13,586
|
104.23
|
US$1,416,088
|
|
|
2025-02-24 |
2025-02-24 |
PrS
Proposed sale
|
Officer
Officer
|
4,675
104.25
US$487,369
|
4,675
|
104.25
|
US$487,369
|
|
|
2025-02-24 |
2025-02-24 |
PlS
Planned sale
|
Non-Executive Director
|
13,586
-28.0%
104.23
US$1,416,134
|
13,586
-28.0%
|
104.23
|
US$1,416,134
|
|
|
2025-02-21 |
2025-02-21 |
PrS
Proposed sale
|
Officer
Officer
|
4,826
104.64
US$504,993
|
4,826
|
104.64
|
US$504,993
|
|
|
2025-02-21 |
2025-02-21 |
PlS
Planned sale
|
SVP, GC and Corp. Secretary
Officer
|
4,826
-9.5%
104.64
US$504,993
|
4,826
-9.5%
|
104.64
|
US$504,993
|
|
|
2025-02-19 |
2025-02-19 |
PrS
Proposed sale
|
Officer
Officer
|
67,333
105.24
US$7,086,109
|
67,333
|
105.24
|
US$7,086,109
|
|
|
2025-02-19 |
2025-02-19 |
PrS
Proposed sale
|
Officer
Officer
|
1,510
105.35
US$159,078
|
1,510
|
105.35
|
US$159,078
|
|
|
2025-02-19 |
2025-02-19 |
PrS
Proposed sale
|
Officer
Officer
|
3,303
105.19
US$347,443
|
3,303
|
105.19
|
US$347,443
|
|
|
2025-02-19 |
2025-02-19 |
PlS
Planned sale
|
EVP&Pres, Periph Intervent
Officer
|
1,510
-4.4%
105.35
US$159,078
|
1,510
-4.4%
|
105.35
|
US$159,078
|
|
|
2025-02-19 |
2025-02-19 |
PlS
Planned sale
|
EVP, Global Operations
Officer
|
3,303
-13.6%
105.19
US$347,443
|
3,303
-13.6%
|
105.19
|
US$347,443
|
|